Finance entity
All 1 tracked stories fall under one category: earnings. Acadia Pharmaceuticals is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are less corroborated than the beat average, carrying 2 original sources each against 3.2 for the same window.
Last mentioned: Feb 27, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: earnings. Acadia Pharmaceuticals is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are less corroborated than the beat average, carrying 2 original sources each against 3.2 for the same window. Their average consequence score of 5 runs below the beat's 6.2 for that window. Irenic Capital Management appears in 1 tracked Finance story from February 27, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 91 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Irenic Capital Management. Shared-story counts are live from our verified record — not editorial picks.
ACADIA Pharmaceuticals and Alkami Technology reported Q4 results that highlight divergent paths for mid-cap growth entities. While ACADIA focuses on the commercial scaling of its rare disease portfolio, Alkami is battling a significant stock correction despite beating revenue expectations.
Irenic Capital Management is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
